Quantum DFT studies on the drug delivery of favipiravir using pristine and functionalized chitosan nanoparticles.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 Dec 2023
Historique:
received: 18 09 2023
accepted: 06 12 2023
medline: 12 12 2023
pubmed: 12 12 2023
entrez: 11 12 2023
Statut: epublish

Résumé

Considering the spread of the COVID-19 pandemic, finding new drugs along with the development of effective drug delivery methods can help in the treatment of this disease. For this reason, in this research work, the possibility of drug-delivery of Favipiravir (FP), one of the drugs approved in the treatment of COVID-19, by pristine chitosan (Chit) nanoparticles (NP), and functionalized chitosan nanoparticles with N-acylate, N-methyl, O-acetyl, and Oxazoline functional groups was studied using quantum mechanical DFT methods at B3LYP-D3(BJ)/6-311 + g(d,p) theoretical level in water medium. The QTAIM, NBO, DOS, frontier orbital, conceptual-DFT indices, and non-covalent interaction analysis were further implemented to investigate the possible interactions between FP and Chit NPs. The results show that the adsorption of FP on Chit NPs is done through the creation of hydrogen bonds, and the highest absorption energy of - 18.15 kcal/mol between pristine chitosan and FP. In the case of all functionalized Chit NPs, a decrease in the absorption energy is observed, which is more noticeable in the case of N-acylated and O-acetyl functionalize Chit NPs, and indicates the weakening of the van der Waals interactions for these cases. Considering the compatibility of Chit NPs with the human body and their non-toxicity, as well as the fact that factors such as pH, solubility, the ionic strength, and so on can be adjusted to control the release rate using the functionalized Chit NPs, it seems that the results of this work can be a comprehensive guide to design the drug delivery methods of FP drug using Chit NPs, to reduce the symptoms of COVID-19 disease.

Identifiants

pubmed: 38081997
doi: 10.1038/s41598-023-49298-5
pii: 10.1038/s41598-023-49298-5
pmc: PMC10713654
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21984

Informations de copyright

© 2023. The Author(s).

Références

Antiviral Res. 2018 May;153:85-94
pubmed: 29524445
Sci Rep. 2022 Nov 19;12(1):19972
pubmed: 36402905
J Comput Chem. 2013 Jun 15;34(16):1429-37
pubmed: 23483590
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 15;247:119082
pubmed: 33120121
Comput Theor Chem. 2022 Nov;1217:113902
pubmed: 36211195
J Comput Chem. 2004 Sep;25(12):1463-73
pubmed: 15224390
Infect Dis Ther. 2021 Dec;10(4):1907-1931
pubmed: 34296386
J Comput Chem. 2012 Feb 15;33(5):580-92
pubmed: 22162017
J Comput Chem. 2011 May;32(7):1456-65
pubmed: 21370243
Annu Rev Phys Chem. 1995;46:701-28
pubmed: 24341393
Antiviral Res. 2013 Nov;100(2):446-54
pubmed: 24084488
Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098-3100
pubmed: 9900728
Clin Infect Dis. 2023 Feb 8;76(3):e10-e17
pubmed: 36065065
Pharmacol Res Perspect. 2022 Feb;10(1):e00909
pubmed: 34968008
Lancet Respir Med. 2021 Feb;9(2):122-123
pubmed: 33189160
Chem Rev. 2005 Aug;105(8):2999-3093
pubmed: 16092826
Chembiochem. 2021 Mar 16;22(6):939-948
pubmed: 33031623
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Biomol Struct Dyn. 2023;41(21):11437-11449
pubmed: 36591698
Crit Care. 2020 Aug 27;24(1):524
pubmed: 32854738
Med J Armed Forces India. 2020 Oct;76(4):370-376
pubmed: 32895599
Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789
pubmed: 9944570
J Med Virol. 2022 Apr;94(4):1523-1534
pubmed: 34846766
ACS Nano. 2020 Apr 28;14(4):3747-3754
pubmed: 32267678
J Mol Struct. 2021 Dec 15;1246:131253
pubmed: 34376872
Phys Chem Chem Phys. 2009 May 14;11(18):3417-23
pubmed: 19421543
Lancet Infect Dis. 2020 Apr;20(4):398-400
pubmed: 32113510
Biomacromolecules. 2002 Sep-Oct;3(5):1126-8
pubmed: 12217063
Int J Biol Macromol. 2021 Feb 1;169:85-94
pubmed: 33279563
BMJ. 2020 Nov 11;371:m4362
pubmed: 33177042
Lancet Respir Med. 2023 May;11(5):415-424
pubmed: 36528039

Auteurs

Sheyda Ataei (S)

Department of Physical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran.

Ebrahim Nemati-Kande (E)

Department of Physical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran. nemati.ebrahim@gmail.com.

Aidin Bahrami (A)

Department of Physical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran.

Classifications MeSH